Related Experiment Video
Updated: Dec 11, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Optimized calcium supplementation approach in post-dilution CVVHDF using regional citrate anticoagulation
Xiao Bi1, Qi Zhang1, Feng Zhuang1
1Division of Nephrology & Critical Care Nephrology Unit, Shanghai Ninth People's Hospital, Shanghai JiaoTong University, School of Medicine, Shanghai, China.
This study presents an optimized calcium supplementation method for regional citrate anticoagulation during continuous renal replacement therapy. The findings help estimate calcium removal in extracorporeal circuits, improving patient safety.
Area of Science:
- Nephrology
- Intensive Care Medicine
- Biomedical Engineering
Background:
- Regional citrate anticoagulation (RCA) is a preferred method for continuous renal replacement therapy (CRRT).
- Accurate calcium supplementation is critical for RCA safety.
- Optimizing calcium management in post-dilution CVVHDF is essential.
Purpose of the Study:
- To develop an optimized calcium supplementation strategy for RCA in post-dilution CVVHDF.
- To establish a mathematical model for precise calcium management during CRRT with RCA.
Main Methods:
- Twenty-seven patients undergoing post-dilution CVVHDF with RCA were studied.
- Ionized calcium levels were continuously monitored and maintained within a target range.
- Linear regression analysis was used to model non-protein bound calcium clearance and calcium ratios.
Main Results:
- Significant positive correlations were observed between non-protein bound calcium clearance and dialysate flow rates (r=0.647, p<0.001) and ultrafiltration/substitution fluid rates (r=0.525, p=0.005).
- The pre-filter ratio of non-protein bound to total calcium remained constant at approximately 0.83.
- A simplified equation was derived to estimate extracorporeal calcium removal based on clearance and calcium ratio.
Conclusions:
- An optimized calcium supplementation approach for RCA in post-dilution CVVHDF was successfully developed.
- This approach facilitates the estimation of extracorporeal calcium removal.
- The findings support safe and effective RCA by guiding calcium dosage adjustments.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Continuous Renal Replacement Therapy
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

